February 22, 2015 | The Israeli creators of diagnostic capsule technology, Check-Cap announced the pricing for its initial public offering. The company raised $12 million at a company value of $92 million, after money, while also closing a private-placement round worth $12 million. The two totals bring funding in the company to $24 million in this round, and a total of $45 million since the company was founded. The private placement round was led by Chinese company Fosun Pharma together with previous investors like GE Healthcare and Pontifax, among others. Check-Cap develops X-Ray capsules for the diagnosis of intestinal cancers and was founded by Yoav Kimchy.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Facebook comments